Thus, we had hypothesized that enhanced β-cell O-GlcNAcylation by β-Ogt overexpression would confer protection from a HFD challenge; however, female transgenic βOgt overexpressor (Hz) mice developed mild glucose intolerance with reduced fasting serum insulin. The gene discussed is INS; the disease is Glucose intolerance.